By TOM MURPHY, Associated Press Health Writer

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.

Related Articles

Approval of updated shots also came several weeks later than usual, and Pfizer said Tuesday that hurt sales as well.

Many Americans get vaccinations in the fall, to get protection from any disease surges in the coming winter. Experts say interest in COVID-19 shots has been declining, and that trend could pick up this fall due to anti-vaccine sentiment and confusion about whether the shots are necessary.

The Centers for Disease Control and Prevention last month stopped recommending COVID-19 shots for anyone, instead leaving the choice up

See Full Page